X-135985673-C-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS1
This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Ile5Met variant in SLC9A6 is 0.013% in Ashkenazi Jewish sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). Computational analysis prediction tools suggest that the p.Ile5Met variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Ile5Met variant in SLC9A6 is classified as likely benign based on the ACMG/AMP criteria (BS1, BP4). LINK:https://erepo.genome.network/evrepo/ui/classification/CA10524605/MONDO:0010278/016
Frequency
Consequence
NM_001379110.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC9A6 | NM_001379110.1 | c.15C>G | p.Ile5Met | missense_variant | 2/18 | ENST00000630721.3 | NP_001366039.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC9A6 | ENST00000630721.3 | c.15C>G | p.Ile5Met | missense_variant | 2/18 | 4 | NM_001379110.1 | ENSP00000487486.2 | ||
SLC9A6 | ENST00000370695.8 | c.171C>G | p.Ile57Met | missense_variant | 1/16 | 1 | ENSP00000359729.4 | |||
SLC9A6 | ENST00000370698.7 | c.171C>G | p.Ile57Met | missense_variant | 1/16 | 1 | ENSP00000359732.3 | |||
SLC9A6 | ENST00000370701.6 | c.15C>G | p.Ile5Met | missense_variant | 2/17 | 1 | ENSP00000359735.1 |
Frequencies
GnomAD3 genomes AF: 0.0000715 AC: 8AN: 111855Hom.: 0 Cov.: 22 AF XY: 0.0000294 AC XY: 1AN XY: 34029
GnomAD3 exomes AF: 0.0000382 AC: 7AN: 183243Hom.: 0 AF XY: 0.0000591 AC XY: 4AN XY: 67737
GnomAD4 exome AF: 0.0000410 AC: 45AN: 1098201Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 21AN XY: 363567
GnomAD4 genome AF: 0.0000715 AC: 8AN: 111855Hom.: 0 Cov.: 22 AF XY: 0.0000294 AC XY: 1AN XY: 34029
ClinVar
Submissions by phenotype
Christianson syndrome Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | - - |
Likely benign, reviewed by expert panel | curation | ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel | Mar 26, 2021 | The allele frequency of the p.Ile5Met variant in SLC9A6 is 0.013% in Ashkenazi Jewish sub population in gnomAD, which is high enough to be classified as likely benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BS1). Computational analysis prediction tools suggest that the p.Ile5Met variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Ile5Met variant in SLC9A6 is classified as likely benign based on the ACMG/AMP criteria (BS1, BP4). - |
Likely benign, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Aug 29, 2019 | This variant was classified as: Likely benign. The following ACMG criteria were applied in classifying this variant: BS2,BP4. This variant was detected in hemizygous state. - |
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | SLC9A6: BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 27, 2017 | A variant of uncertain significance has been identified in the SLC9A6 gene. The I57M variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The I57M variant is observed in 3/47,771 alleles from individuals of European background, including multiple unrelated hemizygous individuals (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The I57M variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position where amino acids with similar properties to Isoleucine are tolerated across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at